ESC 2019: SGTL2i Beyond Diabetes

Published: 03 Oct 2019

  • Views:

    Views Icon 231
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

In this video, Prof Lars Lund, Professor of Medicine and Cardiology (Karolinska Institute, Stockholm, SE) discusses the emerging data on SGLT2 inhibitors.

This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on

Filmed on site at ESC 2019 by Radcliffe Cardiology.

Videographer: Tom Green



This video was partially funded by an unrestricted educational grant from AstraZeneca.